iAnthus Capital Holdings, Inc. IAN ITHUF reported its financial results for the fourth quarter and year-ended December 31, 2021.
Q4 2021 Financial Highlights
- Revenue totaled $47.7 million, up 4% from the same quarter in the prior year.
- Gross profit was $24.2 million, up 8% from the same quarter in the prior year.
- Gross margin of 50.7%, reflecting an increase of 2.0% from the same quarter in the prior year.
- Net loss of $25.7 million, or a loss of $0.15 per share, compared to a loss of $26.7 million, or a loss of $0.16 per share, in the same quarter in the prior year.
- Adjusted EBITDA, non-GAAP measure, came in positive at $8.2 million, up from $5.2 million from the same quarter in the prior year.
Full-Year 2021 Financial Highlights
- Revenue was $203 million, up 34% from the prior year.
- Gross profit totaled $111.3 million, up 36% from the prior year.
- Gross margin was 54.8%, reflecting an increase of 0.8% from the prior year.
- Net loss amounted to $76.2 million, or a loss of $0.44 per share, compared to a loss of $313.4 million, or a loss of $1.83 per share, in the prior year.
- Adjusted EBITDA came in negative at $42.1 million, up from $8.7 million from the prior year.
In the meantime, the New Jersey cannabis regulatory commission approved iAnthus New Jersey, LLC’s acquisition of 100% of the equity interests of New Jersey license holder MPX New Jersey, LLC. On February 1, 2022, the company closed on its acquisition of MPX NJ.
Photo: Courtesy of Towfiqu barbhuiya on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.